Abstracts - faqs.org

Abstracts

Science and technology

Search abstracts:
Abstracts » Science and technology

Testing of autoimmune therapy begins

Article Abstract:

Autoimmune disease is a disorder whereby an immune response is made to a normal component of the body. Autoimmune diseases such as multiple sclerosis, where the immune system destroys the myelin sheath that surrounds nerve cells, and rheumatoid arthritis, where the joints of the body are affected, are usually treated with drugs that suppress the immune system, However, clinical trials are being conducted in patients with multiple sclerosis and rheumatoid arthritis using oral antigen therapy, in which the specific proteins that trigger the immune system are fed to the individual. A protein of the myelin sheath will be used for multiple sclerosis and the connective tissue protein collagen will be used for rheumatoid arthritis. The administration of the proteins by feeding causes suppression of the immune response to those proteins. The mechanism of this suppression is not certain, but may involve the activation of suppressor T cells, which release a cellular factor, transforming growth factor beta, that inhibits immune cells. Or, it may involve inactivation or elimination of T cells that stimulate the immune response. Clinical trials will also begin for uveitis, an autoimmune disease affecting the retina, using the S protein, a component of the retina that is involved in disease. This type of therapy should not be as toxic to the individuals as immunosuppressive drugs and will be more specific, affecting the response to only that protein. (Consumer Summary produced by Reliance Medical Information, Inc.)

Author: Marx, Jean
Publisher: American Association for the Advancement of Science
Publication Name: Science
Subject: Science and technology
ISSN: 0036-8075
Year: 1991
Care and treatment, Autoimmune diseases, Rheumatoid arthritis, Uveitis, Multiple sclerosis

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Helping neurons find their way

Article Abstract:

Several research teams studying axonal development have that found growing axons are guided to their destinations by chemical repellants as well as attractants. Experimental design and the key molecules found are described.

Author: Marx, Jean
Publisher: American Association for the Advancement of Science
Publication Name: Science
Subject: Science and technology
ISSN: 0036-8075
Year: 1995
Research, Axons, Developmental neurology

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Similar abstracts:
  • Abstracts: Animal carcinogen testing challenged. Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses
  • Abstracts: Testing for carcinogens with rodents. Chairman of the House Science Committee. A changing electric power industry
  • Abstracts: China: a living lab for epidemiology. Ecologists look at the big picture. Economics: bringing it all home
  • Abstracts: ''Superantigens'' may shed light on immune puzzle. The Staphylococcal enterotoxins and their relatives. Unraveling the genetics of fragile X syndrome
  • Abstracts: Tissue, developmental, and tumor-specific expression of divergent transcripts in Wilms tumor. Wilms tumor locus on 11p13 defined by multiple CpG island-associated transcripts
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.